Use for interleukin-33 (IL33) and the IL33 receptor complex
Details for Australian Patent Application No. 2005215528 (hide)
International Classifications
Event Publications
31 August 2006 PCT application entered the National Phase
PCT publication WO2005/079844 Priority application(s): WO2005/079844
30 April 2009 Application Accepted
Published as AU-B-2005215528
3 September 2009 Standard Patent Sealed
11 October 2012 Application for Amendment
The nature of the amendment is: Amend the Patentee to read Merck Sharp & Dohme Corp. . Address for service in Australia - Griffith Hack Level 29, Northpoint 100 Miller Street North Sydney NSW 2060
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2005215527-Methods of modulating IL-23 activity; related reagents
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser